Has Eiman Shafa, MD received payments from drug or device companies?

Yes. Drug and device makers reported $569,635 in general payments to Eiman Shafa, MD across 681 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eiman Shafa, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eiman Shafa, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eiman Shafa, MD

Orthopaedic Surgery of the Spine · Minneapolis, MNNPI 1215258462

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $144,328 and has fallen 66.2% since, to $48,742 in 2025. Among orthopaedic surgery of the spine clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$569,635in general payments, 2019–2025

Across 681 payments — averaging $836.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$414K
Medical Device Business Services, Inc.$127K
Depuy Synthes Products, Inc.$15K
Kuros Biosciences USA, Inc$7K
Johnson & Johnson$1K
Carlsmed, Inc.$1K
plus $5K from 15 others

$650in research payments, 2019–2025

Across 1 payment — averaging $650.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$650

What the payments were for

Consulting fees$232,49941%
Speaking & faculty fees$269,56247%
Travel & lodging$52,6759%
Food & beverage$14,7683%
Education$1300%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	428	$413,565
Medical Device Business Services, Inc.	120	$127,295
Depuy Synthes Products, Inc.	31	$15,038
Kuros Biosciences USA, Inc	8	$6,674
Johnson & Johnson	30	$1,400
Carlsmed, Inc.	7	$1,143
Stryker	4	$1,068
Globus Medical	6	$894
Arthrex	12	$581
Providence Medical Technology, Inc.	1	$442
Si-bone, Inc.	5	$386
Foundation Medical, LLC	4	$251
Augmedics Inc.	3	$184
Seaspine Orthopedics Corporation	2	$136
Cerapedics Inc.	12	$130
Ossdsign USA Incorporated	1	$119
Axis Spine Technologies Inc.	2	$111
Ulrich Medical USA, Inc.	1	$81
Orthofix Medical, Inc.	2	$61
Alphatec Spine, Inc	1	$48
Intrinsic Therapeutics	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MAZOR X SYSTEM$142,752
Mazor X Stealth Edition$74,845
MazorX - Renaissance$19,712
ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$15,620
STEALTHSTATION S8 PLATFORM$15,551
POWEREASE$15,273
CD HORIZON SPINAL SYSTEM$8,153
StealthStation$7,719
MagnetOs$6,480
CONDUIT$5,049
UNID_PASS$4,857
PIVOX Oblique Lateral Spinal System$4,282
Adaptix$3,480
Teligen$3,464
Velys$2,869
CD HORIZON$2,760
SOVEREIGN SPINAL SYSTEM$2,500
AQUAMANTYS$2,449
VIPER$1,672
aprevo$961

How this compares

$569,635 in reported general payments places this provider in the 95th percentile of 39 orthopaedic surgery of the spine providers in Minnesota.

See all orthopaedic surgery of the spine providers in Minnesota →

Medicare billing

Part B allowed, 2024

$162,674

Medicare patients

160

Services billed

463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	51	$426
Methocarbamol	95	$415
Cyclobenzaprine Hcl	31	$145
Methylprednisolone	18	$92
Tizanidine Hcl	14	$26

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Minneapolis

Nathan HendricksonMinneapolis$34K
Jeffrey VargheseMinneapolis$5K
Mark MichaelMinneapolis$4K
Carlos CastroMinneapolis$4K
John LonsteinMinneapolis$268
Glenn ButtermannRoseville$259K
Nicholas WillsEagan$241K
Tenner GuillaumeSaint Paul$163K
Benjamin MuellerFridley$89K
Michael SmithEdina$43K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →